Cardiovascular manifestations secondary to COVID-19: A narrative review - 17/06/22
, A. Trimaille c, O. Weizman d, T. Pezel e, D. Mika f, V. Waldmann g, A. Cohen h, G. Bonnet i, jAbstract |
The coronavirus disease 2019 (COVID-19) pandemic has spread rapidly, becoming a major threat to global health. In addition to having required the adaptation of healthcare workers for almost 2 years, it has been much talked about, both in the media and among the scientific community. Beyond lung damage and respiratory symptoms, the involvement of the cardiovascular system largely explains COVID-19 morbimortality. In this review, we emphasize that cardiovascular involvement is common and is associated with a worse prognosis, and that earlier detection by physicians should lead to better management. First, direct cardiac involvement will be discussed, in the form of COVID-19 myocarditis, then secondary cardiac involvement, such as myocardial injury, myocardial infarction and arrhythmias, will be considered. Finally, worsening of previous cardiovascular disease as a result of COVID-19 will be examined, as well as long-term COVID-19 effects and cardiovascular complications of COVID-19 vaccines.
Il testo completo di questo articolo è disponibile in PDF.Keywords : COVID-19, Cardiovascular system
Abbreviations : ACE2, AF, CHF, CMR, COVID-19, LV, MI, mRNA, OHCA, PE, RV, SARS-CoV-2, STEMI
Mappa
Vol 81
Articolo 100904- maggio 2022 Ritorno al numeroBenvenuto su EM|consulte, il riferimento dei professionisti della salute.
